Table 1.
HR (95% CI) | P | |
---|---|---|
TT1 (ref.) | ||
TT2− | 0.65 (0.53–0.79) | <0.001 |
TT2+ | 0.45 (0.36–0.55) | <0.001 |
TT3 | 0.29 (0.22–0.37) | <0.001 |
Age | 1.02 (1.01–1.02) | <0.001 |
Cytogenetic abnormalities | 1.72 (1.48–2.01) | <0.001 |
HR (95% CI) | P | |
---|---|---|
TT1 (ref.) | ||
TT2− | 0.65 (0.53–0.79) | <0.001 |
TT2+ | 0.45 (0.36–0.55) | <0.001 |
TT3 | 0.29 (0.22–0.37) | <0.001 |
Age | 1.02 (1.01–1.02) | <0.001 |
Cytogenetic abnormalities | 1.72 (1.48–2.01) | <0.001 |